Lee Seung Hwan, Park Kyung Kgi, Chung Mun Su, Chung Byung Ha
Department of Urology, Gangnam Severance Hospital, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea.
Korean J Urol. 2011 Jan;52(1):9-12. doi: 10.4111/kju.2011.52.1.9. Epub 2011 Jan 24.
There are few data regarding the epidemiology of hereditary or familial prostate cancer (PCa) in East Asians, especially in Korean men. Therefore, we evaluated the incidence of familial and hereditary PCa and the relation between socioeconomic status and the incidence of nonsporadic prostate cancer (NSPC).
We collected data from all patients who were treated for PCa at our center between November 2009 and January 2010. All patients were either newly diagnosed or had been diagnosed with PCa and seen as outpatients during the study period.
In a sample of 218 patients with PCa; 25 (11.5%) were NSPC patients, and 193 (88.6%) were sporadic PCa sporadic prostate cancer (SPC) patients. Overall, 11.5% of the patients had a positive family history. There was one hereditary PCa family (three patients, 1.4%) and 11 familial PCa families (22 patients, 10.1%). Patients were divided into three different age groups. Of these, 18 (9.3%) SPC patients and 6 (24%) NSPC patients were diagnosed with the disease at the age of 55 years or younger (p=0.02). Prostate-specific antigen (PSA) levels in the NSPC group were significantly higher than in the SPC group (7.2±3.2 versus 6.3±4.9 ng/ml, p=0.042). SPC patients had larger waist circumferences than did NSPC patients (p=0.041). There were no significant differences between the SPC and NSPC groups in terms of socioeconomic status, Gleason score, pathological stage, or pathologic Gleason grade.
East Asian NSPC patients are diagnosed at earlier ages than are SPC patients, even though the incidence of NSPC in the East Asian population is lower than in Western men.
关于东亚人群,尤其是韩国男性中遗传性或家族性前列腺癌(PCa)的流行病学数据较少。因此,我们评估了家族性和遗传性PCa的发病率以及社会经济地位与非散发性前列腺癌(NSPC)发病率之间的关系。
我们收集了2009年11月至2010年1月期间在本中心接受PCa治疗的所有患者的数据。所有患者均为新诊断或在研究期间被诊断为PCa并作为门诊患者就诊。
在218例PCa患者样本中;25例(11.5%)为NSPC患者,193例(88.6%)为散发性PCa散发性前列腺癌(SPC)患者。总体而言,11.5%的患者有阳性家族史。有1个遗传性PCa家族(3例患者,1.4%)和11个家族性PCa家族(22例患者,10.1%)。患者分为三个不同年龄组。其中,18例(9.3%)SPC患者和6例(24%)NSPC患者在55岁及以下被诊断出患有该疾病(p = 0.02)。NSPC组的前列腺特异性抗原(PSA)水平显著高于SPC组(7.2±3.2对6.3±4.9 ng/ml,p = 0.042)。SPC患者的腰围大于NSPC患者(p = 0.041)。SPC组和NSPC组在社会经济地位、Gleason评分、病理分期或病理Gleason分级方面无显著差异。
东亚NSPC患者比SPC患者诊断年龄更早,尽管东亚人群中NSPC的发病率低于西方男性。